A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetate

Leuprorelin acetate‐induced granulomas in subcutaneous injection sites have been occasionally reported, but there have been no detailed morphological examinations. Histopathology of leuprorelin acetate‐induced granulomas in six patients was studied, and one of them was evaluated by electron microscopy. Study using haematoxylin and eosin staining revealed that there were many intracytoplasmic vacuoles in the granulomas and degeneration of fat tissue. Ultrastructurally, electron‐lucent spherical bodies (microcapsules of leuprorelin acetate products) were observed in the granuloma cells. Needle‐shaped crystalloid structures in lipid droplets (degenerated lipid droplets) were observed in the granuloma cells and fat tissue. Degeneration of fat tissues caused by leuprorelin acetate is one of main factors responsible for granuloma formation.

[1]  H. Azuma,et al.  [Skin reaction induced by subcutaneous injection of LH-RH analogue]. , 2007, Hinyokika kiyo. Acta urologica Japonica.

[2]  A. Barbaud,et al.  Granulome sur le site d’injection de leuproréline retard : réaction à corps étranger à l’excipient ? , 2007 .

[3]  N. Tokuda,et al.  Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer. , 2007, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[4]  N. Tokuda,et al.  Injection-site granulomas due to the administration of leuprorelin acetate for the treatment of prostatic cancer. , 2007, Fukuoka igaku zasshi = Hukuoka acta medica.

[5]  N. Tokuda,et al.  Incidence Rate of Injection-Site Granulomas Resulting from the Administration of Luteinizing Hormone-Releasing Hormone Analogues for the Treatment of Prostatic Cancer , 2007, Yonsei medical journal.

[6]  S. K. Sundaram,et al.  Noninfective cutaneous granuloma with leuprorelin acetate--reality or myth. , 2007, Urology.

[7]  M. Sugiura,et al.  Granuloma caused by subcutaneous injection of leuprorelin acetate product: Case report and histopathological findings , 2006, Journal of dermatology (Print).

[8]  T. Kanekura,et al.  Granulomas induced by subcutaneous injection of leuprorelin acetate , 2006, The Journal of dermatology.

[9]  H. Kanamaru,et al.  [Surgical management of inflammatory granuloma which developed following subcutaneous injection of leuprorelin acetate: a case report]. , 2005, Hinyokika kiyo. Acta urologica Japonica.

[10]  D. Sawamura,et al.  Leuprorelin acetate granulomas: case reports and review of the literature , 2005, The British journal of dermatology.

[11]  G. Hamami,et al.  [Cutaneous epithelioid granulomas caused by subcutaneous infusion of leuprorelin acetate: a case report]. , 2004, Hinyokika kiyo. Acta urologica Japonica.

[12]  M. Saxby.  Leuprorelin acetate granulomas: recurrent subcutaneous nodules mimicking metastatic deposits at injections sites , 2003, BJU international.

[13]  R. Moseley,et al.  Leuprorelin acetate granulomas: recurrent subcutaneous nodules mimicking metastatic deposits at injection sites , 2002, BJU international.

[14]  H. Okada,et al.  Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate. , 1996, Journal of pharmaceutical sciences.

[15]  B. Bernard,et al.  Alterations in brain monoaminergic functioning associated with septal lesion induced hyperreactivity , 1975, Pharmacology Biochemistry and Behavior.

[16]  R. R. Modesto,et al.  Effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone on rabbit adipose tissue. , 1974, Journal of Endocrinology.

[17]  J. Lloreta,et al.  Depot leuprorelin acetate-induced granulomas manifested as persistent suppurative nodules. , 2006, Acta dermato-venereologica.

[18]  A. Kastin,et al.  Lipid mobilizing hormones of the hypothalamus and pituitary. , 1975, Pharmacology, biochemistry, and behavior.